Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy

被引：63
|
作者：
Mizuno, Y
Yoshimura, M
Harada, E
Nakayama, M
Sakamoto, T
Shimasaki, Y
Ogawa, H
Kugiyama, K
Saito, Y
Nakao, K
Yasue, H
机构：
[1] Kumamoto Univ, Sch Med, Dept Cardiovasc Med, Kumamoto 8608556, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto, Japan
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 86卷 / 09期
关键词：
D O I：
10.1016/S0002-9149(00)01147-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1036 / 1040
页数：5
相关论文
共 50 条
  • [21] B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy
    Kaski, J. P.
    Tome-Esteban, M. T.
    Mead-Regan, S. J.
    Pantazis, A.
    Marek, J.
    Deanfield, J. E.
    McKenna, W. J.
    Elliott, P. M.
    HEART, 2008, 94 : A86 - A87
  • [22] B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy
    Kaski, J. P.
    Esteban, M. T. Tome
    Mead-Regan, S.
    Pantazis, A.
    Marek, J.
    Deanfield, J. E.
    McKenna, W. J.
    Elliott, P. M.
    HEART, 2008, 94 (10) : 1307 - 1311
  • [23] Plasma B-type natriuretic peptide measurement is not useful as a screening method for carriers of familial hypertrophic cardiomyopathy
    Brito, D.
    de Oliveira, E. Infante
    Richard, P.
    Komajda, M.
    Madeira, H.
    EUROPEAN HEART JOURNAL, 2005, 26 : 389 - 389
  • [24] Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use
    Boomsma, F
    van den Meiracker, AH
    CARDIOVASCULAR RESEARCH, 2001, 51 (03) : 442 - 449
  • [25] Potential predictive value of B-type natriuretic peptide in disease progression in dilated cardiomyopathy
    Prasad, K
    Baig, MK
    Fredericks, S
    Holt, DW
    Grace, AA
    McKenna, WJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 502A - 502A
  • [26] The role of plasma N-terminal pro B-type natriuretic peptide to predict the clinical course of patients with hypertrophic cardiomyopathy
    Bayrak, Fatih
    Kahveci, Gokhan
    Fotbolcu, Hakan
    Tigen, Kurflat
    Mutlu, Bulent
    Baflaran, Yelda
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2005, 33 (02): : 77 - 83
  • [27] Utility of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy
    Maron, BJ
    Tholakanahalli, VN
    Casey, SA
    Zenovich, AG
    Duprez, D
    Aeppli, DM
    Cohn, JN
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 165A - 165A
  • [28] Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy
    Maron, BJ
    Tholakanahalli, VN
    Zenovich, AG
    Casey, SA
    Duprez, D
    Aeppli, DM
    Cohn, JN
    CIRCULATION, 2004, 109 (08) : 984 - 989
  • [29] Relationship Between Biological Variation in B-Type Natriuretic Peptide and Plasma Renin Concentration in Stable Outpatients With Dilated Cardiomyopathy
    Nishiyama, Keizo
    Tsutamoto, Takayoshi
    Kawahara, Chiho
    Yamaji, Masayuki
    Sakai, Hiroshi
    Yamamoto, Takashi
    Fujii, Masanori
    Horie, Minoru
    CIRCULATION JOURNAL, 2011, 75 (08) : 1897 - 1904
  • [30] Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy
    Monserrat, L
    Hermida, M
    Bouzas, B
    Mosquera, I
    Mahon, N
    Peteiro, J
    Alvarez, N
    Penas-Lado, M
    Crespo, M
    Castro-Beiras, A
    REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (07): : 725 - 732
12345